Clinical Trial

COVID-19, Infectious Diseases Clinical Trial 20203083

[LCID Study Number: 20203083]

A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19

The purpose of this study is to evaluate the efficacy and safety of brexanolone in participants on ventilator support for acute respiratory distress syndrome (ARDS) due to COVID-19.

Disease/Condition: COVID-19, Infectious Diseases

Department: Pulmonary and Critical Care

Status: Active, Not Recruiting

Location: Lahey Hospital & Medical Center (Burlington)

Primary Contact Email:

Clinical Trial Details

View NCT ID 04537806 on

Protocol #: 20203083

Principal Investigator(s): James M. Dargin

Study Coordinator(s): Yuxiu Lei

Trial Phase: Sponsor Initiated Study Phase 3